Zee Business Managing Editor and renowned Market Guru Anil Singhvi said that Wockhardt can be bought around levels of Rs 650 – Rs 651. He said that technically, the stock seems to be poised for a bigger upmove from here on. 

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Singhvi said that the Hospital and Pharma sector seems to be in focus and it looks that they can make a further upmove from here on. Manufacturing facilities will be required to develop the vaccines that India is importing and hence stocks like Shilpa Medicare are seeing strong traction. Many companies will benefit from this move and so companies in Pharma space with good manufacturing facilities will benefit going ahead.

See Zee Business Live TV Streaming Below:

Singhvi said that the intra-day target on the share price is Rs 665, with stop-loss of Rs 630. The stock can also see levels of Rs 670 in short term and Rs 690 in positional term going ahead. Singhvi said that the stock can eventually see targets of Rs 750 in the long term.

Market Expert, Rakesh Bansal said that the stock can see a target of Rs 730 – Rs 750 from here on.